JP2002529066A5 - - Google Patents

Download PDF

Info

Publication number
JP2002529066A5
JP2002529066A5 JP2000581045A JP2000581045A JP2002529066A5 JP 2002529066 A5 JP2002529066 A5 JP 2002529066A5 JP 2000581045 A JP2000581045 A JP 2000581045A JP 2000581045 A JP2000581045 A JP 2000581045A JP 2002529066 A5 JP2002529066 A5 JP 2002529066A5
Authority
JP
Japan
Prior art keywords
seq
polynucleotide
ctgf
guc
cag
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000581045A
Other languages
English (en)
Japanese (ja)
Other versions
JP4698837B2 (ja
JP2002529066A (ja
Filing date
Publication date
Priority claimed from US09/187,478 external-priority patent/US6348329B1/en
Application filed filed Critical
Priority claimed from PCT/US1999/026189 external-priority patent/WO2000027868A2/en
Publication of JP2002529066A publication Critical patent/JP2002529066A/ja
Publication of JP2002529066A5 publication Critical patent/JP2002529066A5/ja
Application granted granted Critical
Publication of JP4698837B2 publication Critical patent/JP4698837B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2000581045A 1998-11-06 1999-11-05 結合組織成長因子(ctgf)および使用方法 Expired - Lifetime JP4698837B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/187,478 1998-11-06
US09/187,478 US6348329B1 (en) 1998-11-06 1998-11-06 Nucleic acids encoding rat connective tissue growth factor (CTGF) and methods of use
US09/292,036 US6358741B1 (en) 1998-11-06 1999-04-14 Connective tissue growth factor (CTGF) and methods of use
US09/292,036 1999-04-14
PCT/US1999/026189 WO2000027868A2 (en) 1998-11-06 1999-11-05 Connective tissue growth factor (ctgf) and methods of use

Publications (3)

Publication Number Publication Date
JP2002529066A JP2002529066A (ja) 2002-09-10
JP2002529066A5 true JP2002529066A5 (cg-RX-API-DMAC7.html) 2007-01-11
JP4698837B2 JP4698837B2 (ja) 2011-06-08

Family

ID=22689164

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000581045A Expired - Lifetime JP4698837B2 (ja) 1998-11-06 1999-11-05 結合組織成長因子(ctgf)および使用方法

Country Status (4)

Country Link
US (3) US6348329B1 (cg-RX-API-DMAC7.html)
JP (1) JP4698837B2 (cg-RX-API-DMAC7.html)
KR (1) KR20010102943A (cg-RX-API-DMAC7.html)
HK (1) HK1039342A1 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562618B1 (en) * 1997-12-25 2003-05-13 Japan Tobacco, Inc. Monoclonal antibody against connective tissue growth factor and medicinal uses thereof
MXPA01005949A (es) * 1998-12-14 2002-09-18 Univ Miami Fragmentos de factor de crecimiento de tejido conectivo y metodos y usos de los mismos.
US7115390B1 (en) * 1998-12-14 2006-10-03 Fibrogen, Inc. Connective tissue growth factor fragments and methods and uses thereof
US6444657B1 (en) * 1998-12-31 2002-09-03 Guilford Pharmaceuticals Inc. Methods for treating certain diseases using naaladase inhibitors
US6965025B2 (en) * 2001-12-10 2005-11-15 Isis Pharmaceuticals, Inc. Antisense modulation of connective tissue growth factor expression
EP1616568A3 (en) 2002-04-30 2006-06-21 Alcon, Inc GSK-3 inhibitors and CDK inhibitors as anti-glaucoma agents
EP1497420A4 (en) * 2002-04-30 2005-04-27 Alcon Inc AGENTS THAT REGULATE, RESTRICT OR MODULATE THE ACTIVITY AND / OR EXPRESSION OF BIND WEAVE GROWTH FACTOR (CTGF) AS UNIQUE MEDICAMENTS BOTH TO REDUCE EYESPRINTS AND TREAT GLACCOMPETOSIS RETINOPATHIES / OPTIC NEUROPATHIES
WO2003102161A2 (en) * 2002-06-04 2003-12-11 Metabolex, Inc. Methods of diagnosing & treating diabetes and insulin resistance
US7405274B2 (en) 2003-06-04 2008-07-29 Fibrogen, Inc. Connective tissue growth factor antibodies
WO2005033136A1 (en) * 2003-09-29 2005-04-14 Children's Hospital, Inc. Unique integrin binding site in connective tissue growth factor (ctgf)
CA2555789A1 (en) * 2004-02-11 2005-08-25 Fibrogen, Inc. Ctgf as target for the therapy of diabetic nephropathy
TWI386225B (zh) * 2004-12-23 2013-02-21 Alcon Inc 用於治療眼睛病症的結締組織生長因子(CTGF)RNA干擾(RNAi)抑制技術
US20060275797A1 (en) * 2005-03-21 2006-12-07 Alcon Manufacturing, Ltd. Use of agents which inhibit connective tissue growth factor (CTGF) binding and signaling via the TrkA/p75NTR receptor complex for the prevention and treatment of CTGF-mediated ocular disorders
US20100034892A1 (en) 2006-08-30 2010-02-11 The Trustees Of Columbia University In The City Of New York Treatment for bone formation disorders by growth factor delivery
CN107083386A (zh) 2008-08-25 2017-08-22 埃克斯雷德制药有限公司 阻止结缔组织生长因子的反义核苷酸及其用途
US8946172B2 (en) * 2008-08-25 2015-02-03 Excaliard Pharmaceuticals, Inc. Method for reducing scarring during wound healing using antisense compounds directed to CTGF
EP2448971A1 (en) 2009-07-02 2012-05-09 Fibrogen, Inc. Methods for treatment of muscular dystrophy
WO2011056234A1 (en) 2009-11-06 2011-05-12 Fibrogen, Inc. Treatment for radiation-induced disorders
WO2012061811A2 (en) 2010-11-05 2012-05-10 Fibrogen, Inc. Treatment method for lung remodeling diseases
DK2670411T3 (da) 2011-02-02 2019-05-13 Excaliard Pharmaceuticals Inc Antisense-forbindelser rettet mod bindevævsvækstfaktor (CTGF) til anvendelse i en fremgangsmåde til behandling af keloider eller hypertrofiske ar
US8802839B2 (en) 2011-07-15 2014-08-12 Fibrogen, Inc. Connective tissue growth factor antisense oligonucleotides
EP3386544B1 (en) 2015-12-10 2020-11-25 Fibrogen, Inc. Methods for treatment of motor neuron diseases
US20200369759A1 (en) 2019-05-23 2020-11-26 Fibrogen, Inc. Methods of treatment of muscular dystrophies

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5094941A (en) 1987-12-31 1992-03-10 Zymogenetics, Inc. Monoclonal antibodies to PDGF
US5147294A (en) 1990-10-01 1992-09-15 Trustees Of Boston University Therapeutic method for reducing chronic pain in a living subject
JPH06503966A (ja) 1990-12-21 1994-05-12 クリエイティブ バイオモレキュルズ インコーポレイテッド 生合成したpdgfアンタゴニスト
US5408040A (en) 1991-08-30 1995-04-18 University Of South Florida Connective tissue growth factor(CTGF)
US5770209A (en) 1991-08-30 1998-06-23 University Of South Florida Acceleration of wound healing using connective tissue growth factor
US5596090A (en) * 1992-07-24 1997-01-21 The United States Of America As Represented By The Secretary Of The Navy Antisense oligonucleotides directed against human VCAM-1 RNA
US5916756A (en) 1993-12-14 1999-06-29 University Of South Florida Assay of connective tissue growth factor for detection of cell proliferative disorders
JP4537507B2 (ja) * 1997-12-25 2010-09-01 アムジェン インコーポレイテッド 結合組織増殖因子に対するモノクローナル抗体及びその医薬用途
US6562618B1 (en) * 1997-12-25 2003-05-13 Japan Tobacco, Inc. Monoclonal antibody against connective tissue growth factor and medicinal uses thereof

Similar Documents

Publication Publication Date Title
JP7658592B2 (ja) 非組み込みウイルス送達系およびその関連方法
Rokeach et al. Molecular cloning of a cDNA encoding the human Sm-D autoantigen.
JP2026041749A5 (cg-RX-API-DMAC7.html)
CN108929870B (zh) 抑制HBV的siRNA分子及其应用
EP2966170A1 (en) HBV inactivation
JP2022519761A5 (cg-RX-API-DMAC7.html)
JP2024511163A5 (cg-RX-API-DMAC7.html)
JP2008525033A5 (cg-RX-API-DMAC7.html)
JP2003516731A5 (cg-RX-API-DMAC7.html)
CA3134944A1 (en) Engineered mrna sequences and uses thereof
JPH06500012A (ja) ウィルス(hiv)増殖抑制
JP2001503277A (ja) ウイルス変種およびその検出方法
JP2024511131A5 (cg-RX-API-DMAC7.html)
Taylor Hepatitis delta virus
JP2021518159A5 (cg-RX-API-DMAC7.html)
JP2024534639A5 (cg-RX-API-DMAC7.html)
US6338949B1 (en) Nucleic acids encoding receptor recognition factor stat4 and methods of use thereof
JP2024116343A (ja) ヘパピティスbウイルス複製およびヘパピティスbウイルス表面抗原分泌の抑制方法
CN109929865A (zh) 基于gal4-uas系统的crispr辅助反式增强子激活基因表达的方法及其应用
CA2202519A1 (en) Cloning, expression and characterization of a new form of phosphatidylinositol-3-kinase
Grötzinger et al. A highly amplified mouse gene is homologous to the human interferon-responsive Sp100 gene encoding an autoantigen associated with nuclear dots
JP7754829B2 (ja) インビトロトランスクリプトmrna及びこれを含有する薬学組成物
JPS62270599A (ja) インターフェロンにより誘導されるヒト蛋白質に対するモノクローナル抗体
WO2025045078A1 (zh) 一种用于调控rna甲基化修饰的编辑系统及其应用
WO2022217072A1 (en) Rapid drug-screening platform using crispr gain-of-function approach and pseudoviral selection assay to identify clinical biomarker and anti-viral drug targets